Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Biology of Sex Differences|April 16, 2020
Calorie intake is associated with weight gain during transition phase of nutrition in female extremely low birth weight infantsPradeep Alur, Renjithkumar Kalikkot Thekkeveedu, Madaleine Meeks, et al.
Bioorganic & Medicinal Chemistry Letters|February 27, 2015
Discovery of hydroxyaniline amides as selective Extracellular Regulated Kinase (Erk) inhibitorsHugh Y Zhu, Jagdish Desai, Yongqi Deng, et al.
European Journal of Pediatric Surgery : Official Journal of Austrian Association of Pediatric Surgery ... [Et Al] = Zeitschrift Fur Kinderchirurgie|August 13, 2015
SNAPPE II Score As a Predictor of Survival in Neonates with Congenital Diaphragmatic Hernia: A Single Center ExperienceLouisa W Chiu, Jagdish Desai, Christina Shanti, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferaseAlan B Cooper, Corey L Strickland, James Wang, et al.
Cureus|March 3, 2023
Anemia as a Significant Predictor of Adverse Outcomes in Hospitalized Patients With Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Analysis of National (Nationwide) Inpatient Sample DatabaseHardik Sonani, Kartik Dhaduk, Nilesh Dankhara, et al.
Bioorganic & Medicinal Chemistry Letters|January 9, 2010
Discovery of C-imidazole azaheptapyridine FPT inhibitorsHugh Y Zhu, Alan B Cooper, Jagdish Desai, et al.
Bioorganic & Medicinal Chemistry Letters|January 28, 2014
New class of azaheptapyridine FPT inhibitors as potential cancer therapy agentsHugh Y Zhu, Jagdish Desai, Alan B Cooper, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2017
Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritisSobhana Babu Boga, Abdul-Basit Alhassan, Jian Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 12, 2018
Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncologySobhana Babu Boga, Abdul-Basit Alhassan, Alan B Cooper, et al.
ACS Medicinal Chemistry Letters|July 24, 2018
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for OncologySobhana Babu Boga, Yongqi Deng, Liang Zhu, et al.
Pageof 3